https://www.selleckchem.com/pr....oducts/ITF2357(Givin
5% vs 6.7%, P=0.001), resulting in a 4-fold decrease in VA-related complications. In 204 consecutive patients who underwent VM-facilitated USG-VA, FV diameters significantly increased during VM in both vertical (mean [SD] 10.1[3]mm vs 14.4[3.2]mm; P less then 0.001) and horizontal axis (10.6[2.9]mm vs 14.5[3.2]mm, P less then 0.001). This led to a mean (SD) 38% increase in EAA from 0.8(0.2)cm2 at baseline to 1.1(0.2)cm2 during VM (P less then 0.001). CONCLUSIONS USG-VA for EPS and/or CA is feasible. Complication rates using
Like
Comment
Share
